1 | 0 MG prednisone | - | - | - | - | 1件: 44 44 💬
|
2 | 5 MG prednisone | - | - | - | - | 1件: 44 44 💬
|
3 | AB-101 | - | - | - | - | 4件: 35 35, 44, 46, 49 💬
|
4 | Abatacept | 1件: Abatacept Abatacept | 1件: Abatacept
Abatacept
💬
| 2件: CD80 CD80, CD86 💬
| 13件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | 26件: 2 2, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
|
5 | Active comparator | - | - | - | - | 5件: 6 6, 43, 44, 46, 96 💬
|
6 | Alemtuzumab | 1件: Alemtuzumab Alemtuzumab | 1件: Alemtuzumab
Alemtuzumab
💬
| - | - | 18件: 13 13, 15, 19, 20, 36, 43, 44, 46, 51, 60, 65, 85, 96, 107, 283, 284, 285, 326 💬
|
7 | ANTI-interleukin 5 (IL-5) humanized monoclonal | - | - | - | - | 2件: 44 44, 45 💬
|
8 | Avacopan | 1件: Avacopan Avacopan | 1件: Avacopan
Avacopan
💬
| 1件: C5AR1 C5AR1 💬
| 6件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Staphylococcus aureus infection 💬 | 4件: 43 43, 44, 66, 222 💬
|
9 | Azathioprin-ratiopharm® 25 MG filmtabletten | - | - | - | - | 1件: 44 44 💬
|
10 | Azathioprine | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 22件: 6 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 55, 63, 65, 66, 84, 85, 94, 95, 96, 97, 162 💬
|
11 | Azathioprine 25 MG | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 1件: 44 44 💬
|
12 | AZD7986 | - | - | - | - | 2件: 44 44, 299 💬
|
13 | Belimumab | 1件: Belimumab Belimumab | 1件: Belimumab
Belimumab
💬
| 1件: TNFSF13B TNFSF13B 💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 13件: 11 11, 13, 43, 44, 46, 49, 51, 53, 63, 66, 95, 222, 296 💬
|
14 | Benralizumab | 1件: Benralizumab Benralizumab | 1件: Benralizumab
Benralizumab
💬
| 1件: IL5RA IL5RA 💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | 5件: 44 44, 45, 98, 162, 299 💬
|
15 | Blisibimod | 1件: Blisibimod Blisibimod | 1件: Blisibimod
Blisibimod
💬
| - | - | 5件: 43 43, 44, 49, 63, 66 💬
|
16 | CCX168 | - | - | - | - | 6件: 43 43, 44, 49, 66, 109, 222 💬
|
17 | Chimeric monoclonal antibody, IGG4 subtype | - | - | - | - | 2件: 43 43, 44 💬
|
18 | Corticosteroid and azathioprine | - | - | - | - | 4件: 42 42, 43, 44, 45 💬
|
19 | Cyclophosphamide | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 44件: 11 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 93, 96, 162, 164, 172, 205, 221, 222, 224, 265, 274, 283, 284, 285, 288, 326, 331 💬
|
20 | Cyclophosphamide followed BY methotrexate (azathioprine) + glucocorticoids or methotrexate (azathioprine) + glucocorticoids | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 1件: 44 44 💬
|
21 | Cyclophosphamide/azathioprine | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 1件: 44 44 💬
|
22 | Cyclophosphamidum 500 MG | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 1件: 44 44 💬
|
23 | Depemokimab | 1件: Depemokimab Depemokimab | 1件: Depemokimab
Depemokimab
💬
| 1件: IL5 IL5 💬
| 13件: Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬 | 2件: 44 44, 45 💬
|
24 | Endoxan® 500 MG | - | - | - | - | 1件: 44 44 💬
|
25 | Fasenra | 1件: Benralizumab Benralizumab | 1件: Benralizumab
Benralizumab
💬
| 1件: IL5RA IL5RA 💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | 5件: 44 44, 45, 98, 162, 299 💬
|
26 | Fludarabine | 1件: Fludarabine Fludarabine | 2件: Fludarabine phosphate
Fludarabine phosphate
,
Fludarabine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 23件: 11 11, 13, 19, 34, 35, 36, 44, 46, 49, 51, 60, 61, 62, 65, 85, 96, 107, 164, 222, 283, 284, 285, 326 💬
|
27 | Galen® tablet | - | - | - | - | 2件: 43 43, 44 💬
|
28 | Glucocorticoids | - | - | - | - | 10件: 35 35, 40, 41, 43, 44, 75, 96, 221, 222, 300 💬
|
29 | Glucocorticoids - reduced dose | - | - | - | - | 2件: 43 43, 44 💬
|
30 | Glucocorticoids - standard dose | - | - | - | - | 2件: 43 43, 44 💬
|
31 | GSK3511294 | - | - | - | - | 2件: 44 44, 45 💬
|
32 | Gusperimus | 1件: Gusperimus Gusperimus | 2件: Gusperimus trihydrochloride
Gusperimus trihydrochloride
,
Gusperimus
💬
| - | - | 1件: 44 44 💬
|
33 | Gusperimus + glucocorticoids | 1件: Gusperimus Gusperimus | 2件: Gusperimus trihydrochloride
Gusperimus trihydrochloride
,
Gusperimus
💬
| - | - | 1件: 44 44 💬
|
34 | Hydroxychloroquine | 1件: Hydroxychloroquine Hydroxychloroquine | 2件: Hydroxychloroquine sulfate
Hydroxychloroquine sulfate
,
Hydroxychloroquine
💬
| - | - | 26件: 6 6, 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 63, 66, 84, 96, 97, 107, 218, 222, 224, 234, 254, 271, 298, 299 💬
|
35 | Idefirix | 1件: Imlifidase Imlifidase | 1件: Imlifidase
Imlifidase
💬
| - | - | 3件: 43 43, 44, 113 💬
|
36 | IFX-1 | 1件: Vilobelimab Vilobelimab | 1件: Vilobelimab
Vilobelimab
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 3件: 43 43, 44, 269 💬
|
37 | Imlifidase | 1件: Imlifidase Imlifidase | 1件: Imlifidase
Imlifidase
💬
| - | - | 4件: 43 43, 44, 113, 221 💬
|
38 | Immunoglobulin G cleaving cystein protease derived from E. coli | - | - | - | - | 2件: 43 43, 44 💬
|
39 | Imurel | - | - | - | - | 7件: 13 13, 44, 45, 46, 54, 96, 97 💬
|
40 | Imurel 25 MG | - | - | - | - | 3件: 44 44, 45, 96 💬
|
41 | INS1007 | - | - | - | - | 2件: 44 44, 299 💬
|
42 | L04ac06 | - | - | - | - | 2件: 44 44, 45 💬
|
43 | Laboratory experiments before and after mepolizumab treatment | - | - | - | - | 2件: 44 44, 45 💬
|
44 | Mabthera | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 17件: 11 11, 13, 35, 43, 44, 45, 46, 50, 51, 52, 61, 63, 64, 65, 83, 162, 222 💬
|
45 | MEDI-563 | - | - | - | - | 5件: 44 44, 45, 98, 162, 299 💬
|
46 | Meperizumab injection | - | - | - | - | 1件: 44 44 💬
|
47 | Mepolizumab | 1件: Mepolizumab Mepolizumab | 1件: Mepolizumab
Mepolizumab
💬
| 1件: IL5 IL5 💬
| 13件: Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬 | 4件: 44 44, 45, 98, 162 💬
|
48 | Mesna | - | - | - | - | 11件: 11 11, 13, 44, 45, 49, 51, 60, 65, 85, 96, 164 💬
|
49 | Metex 2,5 MG tabletten | - | - | - | - | 1件: 44 44 💬
|
50 | Methotrexate | 1件: Methotrexate Methotrexate | 2件: Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| 2件: DHFR DHFR, DHFR 💬
| 3件: Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | 37件: 11 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 54, 55, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 284, 285, 286, 326, 331 💬
|
51 | Methotrexate 2.5 MG | 1件: Methotrexate Methotrexate | 2件: Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| 2件: DHFR DHFR, DHFR 💬
| 3件: Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | 1件: 44 44 💬
|
52 | Methotrexate 25 MG | 1件: Methotrexate Methotrexate | 2件: Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| 2件: DHFR DHFR, DHFR 💬
| 3件: Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | 1件: 44 44 💬
|
53 | Metoject 10 MG/ML, solution injectable EN seringue PRé-remplie | 1件: Methotrexate Methotrexate | 2件: Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| 2件: DHFR DHFR, DHFR 💬
| 3件: Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | 1件: 44 44 💬
|
54 | Mycophenolate mofetil | 2件: Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid | 4件: Mycophenolate mofetil
Mycophenolate mofetil
,
Mycophenolate mofetil hydrochloride
,
Mycophenolate sodium
,
Mycophenolic acid
💬
| 2件: IMPDH IMPDH, IMPDH 💬
| 2件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | 32件: 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 46, 49, 51, 53, 60, 62, 63, 65, 66, 93, 95, 96, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬
|
55 | Mycophénolate MOFéTIL | - | - | - | - | 1件: 44 44 💬
|
56 | Naltrexone hydrochloride | 1件: Naltrexone Naltrexone | 2件: Naltrexone hydrochloride
Naltrexone hydrochloride
,
Naltrexone
💬
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬
| 7件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 9件: 10 10, 40, 41, 42, 43, 44, 45, 96, 97 💬
|
57 | NO plasma exchange | - | - | - | - | 2件: 43 43, 44 💬
|
58 | NS-229 | - | - | - | - | 2件: 44 44, 45 💬
|
59 | Nucala | 1件: Mepolizumab Mepolizumab | 1件: Mepolizumab
Mepolizumab
💬
| 1件: IL5 IL5 💬
| 13件: Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬 | 2件: 44 44, 45 💬
|
60 | Nucala 100 MG powder FOR solution FOR injection | 1件: Mepolizumab Mepolizumab | 1件: Mepolizumab
Mepolizumab
💬
| 1件: IL5 IL5 💬
| 13件: Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬 | 2件: 44 44, 45 💬
|
61 | Obinutuzumab | 1件: Obinutuzumab Obinutuzumab | 1件: Obinutuzumab
Obinutuzumab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 5件: 43 43, 44, 49, 63, 222 💬
|
62 | Orencia | 1件: Abatacept Abatacept | 1件: Abatacept
Abatacept
💬
| 2件: CD80 CD80, CD86 💬
| 13件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | 15件: 44 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 160, 222, 271, 300 💬
|
63 | Pednisone | - | - | - | - | 2件: 43 43, 44 💬
|
64 | Plaquenil - hydroxychloroquine 200MG film coated tablets | 1件: Hydroxychloroquine Hydroxychloroquine | 2件: Hydroxychloroquine sulfate
Hydroxychloroquine sulfate
,
Hydroxychloroquine
💬
| - | - | 3件: 43 43, 44, 45 💬
|
65 | Plasma exchange | - | - | - | - | 7件: 13 13, 43, 44, 64, 95, 171, 222 💬
|
66 | Prednisolone | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 38件: 3 3, 11, 13, 14, 18, 25, 26, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 54, 56, 60, 63, 64, 66, 81, 84, 85, 96, 97, 113, 145, 162, 222, 251, 269, 271, 296, 299, 300 💬
|
67 | Prednison acis® 20 MG | - | - | - | - | 2件: 43 43, 44 💬
|
68 | Prednison acis® 5 MG | - | - | - | - | 2件: 43 43, 44 💬
|
69 | Prednison acis¿ 20 MG | - | - | - | - | 2件: 43 43, 44 💬
|
70 | Prednison acis¿ 5 MG | - | - | - | - | 2件: 43 43, 44 💬
|
71 | Prednisone | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 54件: 2 2, 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 145, 162, 164, 205, 222, 224, 228, 251, 269, 283, 285, 288, 299, 300, 303, 307, 331 💬
|
72 | Prednisone tablets, USP | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 41 41, 43, 44 💬
|
73 | Procalcitonin-variants elisa-assay | 1件: Procalcitonin Procalcitonin | - | - | - | 2件: 43 43, 44 💬
|
74 | Rapcabtagene autoleucel | - | - | - | - | 3件: 43 43, 44, 51 💬
|
75 | Recombinant humanized monoclonal antibody specific FOR human IL-5 | - | - | - | - | 1件: 44 44 💬
|
76 | Reslizumab | 1件: Reslizumab Reslizumab | 1件: Reslizumab
Reslizumab
💬
| 1件: IL5 IL5 💬
| 13件: Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬 | 2件: 44 44, 98 💬
|
77 | Rituximab | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 52件: 11 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 172, 220, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
|
78 | RO0452294/V01 | - | - | - | - | 2件: 43 43, 44 💬
|
79 | RO0452294/V02 | - | - | - | - | 3件: 35 35, 43, 44 💬
|
80 | Roactemra | 1件: Tocilizumab Tocilizumab | 1件: Tocilizumab
Tocilizumab
💬
| 1件: IL6R IL6R 💬
| 11件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 7件: 41 41, 44, 46, 51, 86, 107, 271 💬
|
81 | SB-240563 | - | - | - | - | 3件: 44 44, 45, 98 💬
|
82 | SHR-1703 | - | - | - | - | 1件: 44 44 💬
|
83 | Tezepelumab | 1件: Tezepelumab Tezepelumab | 1件: Tezepelumab
Tezepelumab
💬
| 1件: TSLP TSLP 💬
| 2件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬 | 3件: 44 44, 45, 98 💬
|
84 | Tocilizumab | 1件: Tocilizumab Tocilizumab | 1件: Tocilizumab
Tocilizumab
💬
| 1件: IL6R IL6R 💬
| 11件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 24件: 2 2, 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬
|
85 | Tofacitinib | 1件: Tofacitinib Tofacitinib | 2件: Tofacitinib citrate
Tofacitinib citrate
,
Tofacitinib
💬
| 4件: JAK1 JAK1, JAK2, JAK3, TYK2 💬
| 39件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 19件: 35 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 65, 66, 96, 97, 107, 110, 162, 271, 300 💬
|
86 | Trimethoprim sulfamethoxazole | 1件: Trimethoprim Trimethoprim | 3件: Trimethoprim
Trimethoprim
,
Trimethoprim sulfate
,
Trimethoprim hydrochloride
💬
| - | - | 1件: 44 44 💬
|
87 | Vilobelimab | 1件: Vilobelimab Vilobelimab | 1件: Vilobelimab
Vilobelimab
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 3件: 43 43, 44, 269 💬
|
88 | Vitamin D | 1件: Vitamin D Vitamin D | - | - | - | 20件: 6 6, 13, 19, 41, 43, 44, 46, 49, 50, 68, 93, 95, 96, 97, 179, 222, 228, 235, 274, 299 💬
|
89 | Yellow fever vaccine | 1件: Yellow fever vaccine Yellow fever vaccine | 1件: Yellow fever vaccine
Yellow fever vaccine
💬
| - | - | 8件: 40 40, 44, 46, 50, 51, 52, 53, 107 💬
|